Podcast: Nokia, Audi and Bird & Bird debate FRAND
Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX
Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Podcast: Nokia, Audi and Bird & Bird debate FRAND

Sponsored by

twobirds-400px.jpg
Clemens Heusch at Nokia (left), Richard Vary at Bird & Bird (middle), Matthias Schneider at Audi (right)

Richard Vary, Clemens Heusch and Matthias Schneider reveal their views on component-level versus end-point licensing and Unwired Planet

To listen to the full podcast, which is around 40 minutes, click the link above.

In the first of three Bird & Bird-sponsored podcasts, Americas editor Patrick Wingrove spoke to Richard Vary, partner at Bird & Bird, Clemens Heusch, global head of dispute resolution at Nokia, and Matthias Schneider, chief licensing officer at Audi, about standard essential patent licensing.

Here, Vary, Heusch and Schneider debate issues of fair, reasonable and non-discriminatory terms in the context of component-level versus end-point licensing, and the recent UK Supreme Court decision in Unwired Planet v Huawei.

We would like to thank Bird & Bird for making this podcast possible and for lending the necessary expertise in this matter. 

To discuss the details of this episode and find out how Bird & Bird can make the most of your IP portfolio, please contact Richard Vary.


more from across site and ros bottom lb

More from across our site

Counsel say the USPTO's examples of AI patentability should make their lives easier and help point clients in the right direction
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Ehsun Forghany says he was impressed by the firm's focus on fashion and IP as well as the expertise of chairman Anthony Lupo
Counsel at medical device companies say the unitary patent, AI and terminal disclaimers are major areas of concern
The LMG Life Sciences Awards is thrilled to present the shortlist for the 2024 Ameicas Awards
Daniel Wise at Carpmaels & Ransford explains how he helped secure the first UPC revocation ruling on behalf of Sanofi and Regeneron against Amgen
Patent attorney Joanne van Harmelen reflects on how her move from full-service firm ENSafrica to IP outfit Adams & Adams has affected her practice
The EU should press ahead with plans to introduce a unitary SPC and the UPC and EUIPO should play leading roles, says Jörg Thomaier at Bayer
Lawyers reveal how they inform clients about the IP implications of fast-moving private equity deals
View the Social Impact EMEA Awards 2024 shortlist and join us on September 12 at The Waldorf Hotel in London
Gift this article